Invention Grant
- Patent Title: 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
-
Application No.: US13739442Application Date: 2013-01-11
-
Publication No.: US08653268B2Publication Date: 2014-02-18
- Inventor: Mark J. Mulvihill , Radoslaw Laufer , An-Hu Li , Arno G. Steinig
- Applicant: OSI Pharmaceuticals, LLC
- Applicant Address: US NY Farmingdale
- Assignee: OSI Pharmaceuticals, LLC
- Current Assignee: OSI Pharmaceuticals, LLC
- Current Assignee Address: US NY Farmingdale
- Main IPC: C07D471/00
- IPC: C07D471/00 ; C07D487/00 ; C07D491/00 ; C07D495/00 ; C07D497/00
Abstract:
Compounds of the formula and pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, X5, X6, X7, R1, and Q1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.
Public/Granted literature
- US20130190496A1 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors Public/Granted day:2013-07-25
Information query
